SARS News and Research

RSS
Researchers identify a potent new combination of antiviral drugs to combat SARS-CoV-2

Researchers identify a potent new combination of antiviral drugs to combat SARS-CoV-2

9 Feb 2022
Super-resolution imaging of the human coronavirus genome during infection

Super-resolution imaging of the human coronavirus genome during infection

9 Feb 2022
Newborn antibodies following maternal COVID-19 vaccination persist for up to six months

Newborn antibodies following maternal COVID-19 vaccination persist for up to six months

9 Feb 2022
The serious risks COVID-19 may pose during pregnancy

The serious risks COVID-19 may pose during pregnancy

9 Feb 2022
How SARS-CoV-2 infection progresses throughout the respiratory system

How SARS-CoV-2 infection progresses throughout the respiratory system

9 Feb 2022
Impact of genetic changes in Omicron variant on an immunodominant T-cell epitope

Impact of genetic changes in Omicron variant on an immunodominant T-cell epitope

9 Feb 2022
New reagent-free SARS-CoV-2 detection technique based on machine learning and Raman spectroscopy

New reagent-free SARS-CoV-2 detection technique based on machine learning and Raman spectroscopy

9 Feb 2022
UCI case report: Antihistamines may provide relief for people suffering from long COVID-19 symptoms

UCI case report: Antihistamines may provide relief for people suffering from long COVID-19 symptoms

9 Feb 2022
University of Michigan expert discusses about COVID-19 vaccine for kids under 5

University of Michigan expert discusses about COVID-19 vaccine for kids under 5

9 Feb 2022
Exploring omicron infection in COVID-19 vaccinated and convalescent South African healthcare workers

Exploring omicron infection in COVID-19 vaccinated and convalescent South African healthcare workers

9 Feb 2022
Study explores wastewater surveillance of US military installations to mitigate the spread of SARS-CoV-2

Study explores wastewater surveillance of US military installations to mitigate the spread of SARS-CoV-2

9 Feb 2022
Study compares the neutralizing potential of antibodies against two Omicron variants

Study compares the neutralizing potential of antibodies against two Omicron variants

9 Feb 2022
Single-cell sequencing provides detailed insight into early SARS-CoV-2 infection in the lungs

Single-cell sequencing provides detailed insight into early SARS-CoV-2 infection in the lungs

9 Feb 2022
Assessment of multiple sampling strategies to estimate SARS-CoV-2 epidemiological parameters

Assessment of multiple sampling strategies to estimate SARS-CoV-2 epidemiological parameters

9 Feb 2022
Induction and stability of vaccine-specific antibodies in multiple sclerosis patients on different disease-modifying therapies

Induction and stability of vaccine-specific antibodies in multiple sclerosis patients on different disease-modifying therapies

9 Feb 2022
Simulation of SARS-CoV-2 spread in the United States and India

Simulation of SARS-CoV-2 spread in the United States and India

9 Feb 2022
Implications of the SARS-CoV-2 pandemic on influenza epidemics

Implications of the SARS-CoV-2 pandemic on influenza epidemics

9 Feb 2022
Study suggests people with COVID-19 exhibit increased risks and 12-month burdens of incident cardiovascular diseases

Study suggests people with COVID-19 exhibit increased risks and 12-month burdens of incident cardiovascular diseases

9 Feb 2022
Dynamics and longevity of antibody response from COVID-19 convalescents across the clinical spectrum

Dynamics and longevity of antibody response from COVID-19 convalescents across the clinical spectrum

9 Feb 2022
Study explores inflammation of endothelial cells by exosomes from COVID-19 patients

Study explores inflammation of endothelial cells by exosomes from COVID-19 patients

9 Feb 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback